TY - JOUR
T1 - The second survey of the Saudi Acute Myocardial Infarction Registry Program
T2 - Main results and temporal changes in care (STARS-2 program)
AU - STARS-2 Investigators
AU - AlSaleh, Ayman
AU - AlSaif, Shukri M.
AU - Alhadramy, Osama
AU - Alshehri, Mohammed
AU - Faraidy, Khalid Al
AU - Almutairi, Fawaz
AU - Kinsara, Abdulhalim J.
AU - Al-Murayeh, Mushabab
AU - Ghabashi, Abdullah E.
AU - Alasnag, Mirvat
AU - Hussein, Gamal Abdin
AU - Askar, Tamer M.
AU - Haider, Kamel H.
AU - Alharbi, Ibrahim A.
AU - Almokhlef, Abdulaziz
AU - Sayed, Belal A.
AU - Almasswary, Adel
AU - Zia-Ul-Sabah,
AU - Kazim, Hameedullah
AU - Albareda, Hazem A.
AU - Aldossari, Mubarak A.
AU - Albawardi, Rasha
AU - Alali, Rudaynah
AU - Abdulhabeeb, Ibrahim A.M.
AU - Ibrahim, Saifeldin Mohamed
AU - Alasmari, Sami
AU - Almoghairi, Abdulrahman M.
AU - Khoja, Abdullateef Y.
AU - Hussain, Naveed
AU - Aminu, Balarabe S.
AU - Serafi, Abdulhalim
AU - Eltayeb, Abdalla Osman
AU - BuSaleh, Ali Husain
AU - Alsabatien, Basel
AU - Hamza, Mirghani K.
AU - Alsharkawy, Rasha
AU - Awwad, Awatif A.
AU - Mohamed, Maha A.
AU - Al Habeeb, Mohammed A.
AU - Shujauddin, Syed
AU - Ya’u, Jamila Ado
AU - Attia, Nashwa M.
AU - Kholaif, Naji
AU - Bin Ghouth, Nazeeh M.
AU - Youssef, Kheir I.M.
AU - Qutub, Mohammed A.
AU - Lawand, Samih R.
AU - Alkutshan, Raed
AU - Ahmed, Emadaldein
AU - Basardah, Ayman
N1 - Publisher Copyright:
© 2025 AlSaleh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2025/9
Y1 - 2025/9
N2 - Background The Saudi Acute Myocardial Infarction Registry (STARS) program aims to evaluate the clinical characteristics, management, and outcomes of a representative sample of patients with acute myocardial infarction (AMI) in Saudi Arabia. This second phase evaluates temporal changes in patient care, demographics, and the management benchmarks for AMI. Methods and findings We created a 5-year recurring, multi-center prospective registry that utilizes a snapshot design in 50 hospitals from various healthcare sectors in Saudi Arabia. The study’s recruitment phase spanned from September 3, 2021, to January 6, 2023. During these 16 months, 2,690 patients presenting with acute myocardial infarction (AMI) with or without ST-segment elevation (STEMI or NSTEMI, respectively) were enrolled. The mean age (± SD) of the overall population was 57 (±12.4) years, 70% were Saudi citizens, 82% were men, and (48.8%) of the total patients had STEMI. Fifty-eight percent of patients had diabetes mellitus and 58% had hypertension. Of the total population with STEMI, primary percutaneous coronary intervention (PCI) was performed in 619 patients (47.1%), thrombolytics were given to 584 patients (44.5%), and 110 patients had no reperfusion (8.4%). Among patients who presented within 24 h of symptom onset, the door-to-balloon (DTB) time was 63 min (IQR: 43), with 75.6% achieving DTB < 90 min, whereas the door-to-needle (DTN) was 25 min (IQR: 34), with 57% achieving DTN < 60 min. Thirty-nine percent of patients failed lytic reperfusion and 96% of these required rescue PCI. In 52% of instances, the failure to receive reperfusion therapy was attributed to patients’ late presentation. At presentation, only 8.5% of cases were transferred by the Emergency Medical Services. Approximately one-fourth of patients with NSTEMI did not undergo a coronary angiogram. All-cause mortality was 2.4% with no significant difference between sexes or nationalities. Conclusion This nationwide AMI registry revealed younger age at presentation with a high prevalence of risk factors for coronary artery disease. While primary PCI key performance indicators have improved from the previous phase, further progress is needed in EMS utilization and acute revascularization for STEMI and NSTEMI.
AB - Background The Saudi Acute Myocardial Infarction Registry (STARS) program aims to evaluate the clinical characteristics, management, and outcomes of a representative sample of patients with acute myocardial infarction (AMI) in Saudi Arabia. This second phase evaluates temporal changes in patient care, demographics, and the management benchmarks for AMI. Methods and findings We created a 5-year recurring, multi-center prospective registry that utilizes a snapshot design in 50 hospitals from various healthcare sectors in Saudi Arabia. The study’s recruitment phase spanned from September 3, 2021, to January 6, 2023. During these 16 months, 2,690 patients presenting with acute myocardial infarction (AMI) with or without ST-segment elevation (STEMI or NSTEMI, respectively) were enrolled. The mean age (± SD) of the overall population was 57 (±12.4) years, 70% were Saudi citizens, 82% were men, and (48.8%) of the total patients had STEMI. Fifty-eight percent of patients had diabetes mellitus and 58% had hypertension. Of the total population with STEMI, primary percutaneous coronary intervention (PCI) was performed in 619 patients (47.1%), thrombolytics were given to 584 patients (44.5%), and 110 patients had no reperfusion (8.4%). Among patients who presented within 24 h of symptom onset, the door-to-balloon (DTB) time was 63 min (IQR: 43), with 75.6% achieving DTB < 90 min, whereas the door-to-needle (DTN) was 25 min (IQR: 34), with 57% achieving DTN < 60 min. Thirty-nine percent of patients failed lytic reperfusion and 96% of these required rescue PCI. In 52% of instances, the failure to receive reperfusion therapy was attributed to patients’ late presentation. At presentation, only 8.5% of cases were transferred by the Emergency Medical Services. Approximately one-fourth of patients with NSTEMI did not undergo a coronary angiogram. All-cause mortality was 2.4% with no significant difference between sexes or nationalities. Conclusion This nationwide AMI registry revealed younger age at presentation with a high prevalence of risk factors for coronary artery disease. While primary PCI key performance indicators have improved from the previous phase, further progress is needed in EMS utilization and acute revascularization for STEMI and NSTEMI.
UR - https://www.scopus.com/pages/publications/105015003290
U2 - 10.1371/journal.pone.0331215
DO - 10.1371/journal.pone.0331215
M3 - Article
C2 - 40892777
AN - SCOPUS:105015003290
SN - 1932-6203
VL - 20
JO - PLoS ONE
JF - PLoS ONE
IS - 9 September
M1 - e0331215
ER -